English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Amgen Inc.

Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients

Erianne Leatherman | Apr 9, 2017

Amgen’s BLINCYTO to receive priority review from FDA

Erianne Leatherman | Apr 7, 2017

Repatha shows no memory effects while lowering LDL levels, study finds

Robert Hadley | Mar 28, 2017

European Commission approves Amgen's new anti-inflammatory drug

Robert Hadley | Mar 22, 2017

Amgen’s Repatha may help patients with tough cases of high cholesterol

Robert Hadley | Mar 17, 2017

Clinical trial shows immunotherapy can extend leukemia patients' life expectancy

Mark Iandolo | Oct 24, 2016

Amgen announces study regarding its XGEVA product

Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments

Trending

Patient Daily | Oct 22, 2025

Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

Patient Daily | Oct 21, 2025

Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’

  • « First
  • «
  • 1
  • 2
  • 3
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily